Tag: Clinical Trials
DARWIN EU® Welcomes European Medicines Agency (EMA) Selected First Data Partners to Generate Real-World...
EMA has selected the first set of data partners to collaborate with DARWIN EU®, the Data Analysis and Real-World Interrogation Network. The data available to these partners will be used for studies to generate real-world evidence that will support scientific evaluations and regulatory decision making....
New Biobank in UK Created to Advance Research on Pediatric and Young People’s Cancers
VIVO Biobank is supported by the charities Cancer Research UK and Blood Cancer UK and will provide cancer researchers with a centralised collection of cell and tissue samples from children and young people affected by cancer across the country. The samples...
Texas Heart Institute Biorepository Received Equipment Grant from NIH to Support Automation and Modernization
The Texas Heart Institute (THI) Biorepository and Biospecimen Profiling Core Laboratory has received an R24 grant award from the National Institutes of Health (NIH) to support the automation and modernization of the facility’s sample storage and handling process. With this $220,000...
Biobank and Pharma Services now have Commercial Access to Lifespin’s Metabolic Profiler Software and...
Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, announced that it has launched a new commercial service for the pharmaceutical and biobanking industry to assist companies in key phases of research, development, and manufacturing. Immediate applications of...
UK Biocentre Granted ISO 15189:2012 Accreditation for Sample Processing and Storage Services
UK Biocentre has been granted ISO 15189:2012 Accreditation by UKAS for sample processing and storage services. This landmark accreditation further extends UK Biocentre’s capabilities, increasing the scope of services it can provide to support clinical trials and studies, including...
Grünenthal And Mesoblast Partner To Develop Allogeneic Cell Therapy For Chronic Low Back Pain
Grünenthal, a global leader in pain management, and
Mesoblast Limited, a world leader in allogeneic cellular medicines for
inflammatory diseases, have entered into a strategic partnership to develop and
commercialise MPC-06-ID, a Phase III allogeneic cell therapy candidate for the
treatment of chronic...
Mission Bio And Onconova Partner To Use Tapestri® Platform Single-Cell DNA Analysis In Clinical...
Mission Bio, the pioneer in targeted single-cell DNA
analysis and precision genomics, and Onconova Therapeutics, have formed a
collaboration to utilize the Mission Bio Tapestri®
Platform for targeted single-cell DNA analysis to study Onconova’s novel cancer
therapy, rigosertib, through clinical trials. Founded in 2012,...
Meeting – C-Path and NORD Launch The Rare Disease Cures Accelerator-Data and Analytics Platform
The Critical Path Institute (C-Path) and the National Organization for Rare Disorders® (NORD) will host a meeting on Tuesday, September 17 in Bethesda, Maryland, to formally launch development of a new rare disease data and analytics platform. Funded by...
Gamida Cell Presented Omidubicel Cell Therapy For Blood Cancers At ISCT Meeting In Melbourne
Two presentations on omidubicel (formerly known as NiCord®),
an investigational advanced cell therapy in Phase 3 clinical development
designed to enhance the life-saving benefits of hematopoietic stem cell (bone
marrow) transplant, developed by Gamida Cell Ltd., a leading cellular and
immune therapeutics company,...
Circuit Clinical™ Partners With CUBRC Applying Machine Learning To Predict Therapy Response
Circuit Clinical™, one of the USA's largest integrated research organizations dedicated to empowering patients to choose clinical research as a care option, has announced a ground-breaking strategic partnership with CUBRC (Calspan-University at Buffalo Research Center), a company specializing in...
